Metraipolis › archive › dc_3d92d795aaf3
A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer — Europe PMC PMID:41122172
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41122172
- DOI
- 10.3389/fimmu.2025.1681734
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T13:31:21.197Z
- SHA-256 of the archived text
30202a946071b21165acee31c739ad9a9c875b72a57ce4a28cd968b1c0e2dfcb- Stable URL of this page
https://metraipolis.com/documento/dc_3d92d795aaf3
How to cite
A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer — Europe PMC PMID:41122172 — Europe PMC (en), https://europepmc.org/article/MED/41122172 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3d92d795aaf3 (Metraipolis archive dc_3d92d795aaf3, sha256 30202a946071b21165acee31c739ad9a9c875b72a57ce4a28cd968b1c0e2dfcb)
BibTeX
@misc{dc3d92d795aaf3,
title = {A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer — Europe PMC PMID:41122172},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41122172},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3d92d795aaf3; sha256 30202a946071b21165acee31c739ad9a9c875b72a57ce4a28cd968b1c0e2dfcb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41122172. Agents can read the archived copy with the MCP tool read_document.